RIP kinase inhibitor HS-1371, Purity ≥98%

Synonym: 2158197-70-5; HS-1371; HS1371; 7-(1-(Piperidin-4-yl)-1H-pyrazol-4-yl)-4-(p-tolyloxy)quinoline; 4-(4-Methylphenoxy)-7-(1-piperidin-4-ylpyrazol-4-yl)quinoline; RIP kinase inhibitor

CAS Number: 2158197-70-5
Compound CID: 134817449

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

HS-1371, soluble in DMSO and ethanol and insoluble in water, is a compound that targets RIP kinases and is a critical regulator of various cellular processes, including apoptosis, necroptosis, and inflammation.

Molecular Weight

384.47

Molecular Formula

C₂₄H₂₄N₄O

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 12 mg/mL (31.21 mM); Water: Insoluble; Ethanol: 4 mg/mL (10.4 mM)

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

HS-1371 can be studied to understand its role in inhibiting RIPK1 and its therapeutic potential.

Storage

Store at -20ºC.